(Q43257949)

17 November 2017

title

Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent (English)

1 reference

17 November 2017

0 references

1 reference

S Romeo

1

1 reference

17 November 2017

F Sentinelli

2

1 reference

17 November 2017

S Dash

3

1 reference

17 November 2017

G S H Yeo

4

1 reference

17 November 2017

D B Savage

5

1 reference

17 November 2017

F Leonetti

6

1 reference

17 November 2017

D Capoccia

7

1 reference

17 November 2017

M Incani

8

1 reference

17 November 2017

C Maglio

9

1 reference

17 November 2017

M Iacovino

10

1 reference

17 November 2017

S O'Rahilly

11

1 reference

17 November 2017

M G Baroni

12

1 reference

17 November 2017

language of work or name

English

0 references

publication date

20 October 2009

1 reference

International Journal of Obesity

17 November 2017

published in

1 reference

17 November 2017

volume

34

1 reference

17 November 2017

issue

1

1 reference

17 November 2017

page(s)

190-194

1 reference

https://scigraph.springernature.com/pub.10.1038/ijo.2009.216

17 November 2017

exact match

0 references

cites work

Updated definitions of healthy ranges for serum alanine aminotransferase levels

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.216

Statins and hepatic steatosis: perspectives from the Dallas Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.216

7 January 2021

Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.216

7 January 2021

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.216

7 January 2021

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.216

7 January 2021

Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.216

7 January 2021

Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.216

7 January 2021

A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.216

7 January 2021

Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.216

7 January 2021

Search for genetic variants of the SYNTAXIN 1A (STX1A) gene: the -352 A>T variant in the STX1A promoter associates with impaired glucose metabolism in an Italian obese population

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.216

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.216

7 January 2021

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.216

7 January 2021

Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.216

7 January 2021

Transaminase activity in human blood

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.216

7 January 2021

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.216

7 January 2021

A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.216

7 January 2021

Characterization of the human patatin-like phospholipase family

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.216

7 January 2021

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.216

7 January 2021

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.216

7 January 2021

Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.216

7 January 2021

Identifiers

DOI

10.1038/IJO.2009.216

1 reference

Dimensions Publication ID

17 November 2017

1050352071

0 references

1 reference